4.5 Article

Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures

期刊

BREAST CANCER RESEARCH AND TREATMENT
卷 144, 期 3, 页码 503-517

出版社

SPRINGER
DOI: 10.1007/s10549-014-2887-9

关键词

Primary cultures; Tumors; ER-negative breast cancer; Metastatic xenograft models

类别

资金

  1. NIH [1R01 CA113674]
  2. Bankhead Coley Cancer Research Program Pre SPORE Grant [09BW-04]
  3. National Cancer Institute [T32CA119929]
  4. BCRF funds

向作者/读者索取更多资源

Our goal was to establish primary cultures from dissociation of breast tumors in order to provide cellular models that may better recapitulate breast cancer pathogenesis and the metastatic process. Here, we report the characterization of six cellular models derived from the dissociation of primary breast tumor specimens, referred to as dissociated tumor (DT) cells. In vitro, DT cells were characterized by proliferation assays, colony formation assays, protein, and gene expression profiling, including PAM50 predictor analysis. In vivo, tumorigenic and metastatic potential of DT cultures was assessed in NOD/SCID and NSG mice. These cellular models differ from recently developed patient-derived xenograft models in that they can be used for both in vitro and in vivo studies. PAM50 predictor analysis showed DT cultures similar to their paired primary tumor and as belonging to the basal and Her2-enriched subtypes. In vivo, three DT cultures are tumorigenic in NOD/SCID and NSG mice, and one of these is metastatic to lymph nodes and lung after orthotopic inoculation into the mammary fat pad, without excision of the primary tumor. Three DT cultures comprised of cancer-associated fibroblasts (CAFs) were isolated from luminal A, Her2-enriched, and basal primary tumors. Among the DT cells are those that are tumorigenic and metastatic in immunosuppressed mice, offering novel cellular models of ER-negative breast cancer subtypes. A group of CAFs provide tumor subtype-specific components of the tumor microenvironment (TME). Altogether, these DT cultures provide closer-to-primary cellular models for the study of breast cancer pathogenesis, metastasis, and TME.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study

Amber N. Hurson, Mustapha Abubakar, Alina M. Hamilton, Kathleen Conway, Katherine A. Hoadley, Michael Love, Andrew F. Olshan, Charles M. Perou, Montserrat Garcia-Closas, Melissa A. Troester

Summary: This study identified breast cancer risk factors associated with RNA-based TP53 and ER, providing a new etiologic schema of interest in breast cancer prevention research.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Oncology

Gene-Level Germline Contributions to Clinical Risk o f Recurrence Scores in Black and White Patients with Breast Cancer

Achal Patel, Montserrat Garcia-Closas, Andrew F. Olshan, Charles M. Perou, Melissa A. Troester, Michael Love, Arjun Bhattacharya

Summary: This study identifies race-specific genetic associations with breast cancer risk of recurrence scores and suggests mediation of these associations by PAM50 subtype and expression, with implications for clinical interpretation of these scores.

CANCER RESEARCH (2022)

Review Immunology

Advances in the Rapid Diagnostic of Viral Respiratory Tract Infections

Gratiela Gradisteanu Pircalabioru, Florina Silvia Iliescu, Grigore Mihaescu, Alina Irina Cucu, Octavian Narcis Ionescu, Melania Popescu, Monica Simion, Liliana Burlibasa, Mihaela Tica, Mariana Carmen Chifiriuc, Ciprian Iliescu

Summary: Viral infections are a significant public health problem, and laboratory diagnostic tests play a crucial role in improving patient care and infection prevention. This review discusses the progress and potential of micro- and nanotechnology-based solutions for rapidly detecting human viral respiratory infectious diseases, as well as alternative methods such as microfluidics, biosensors, and IoT-based devices.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Oncology

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Carey K. Anders, Mark G. Woodcock, Amanda E. D. Van Swearingen, Dominic T. Moore, Maria J. Sambade, Sonia Laurie, Alexander Robeson, Oleg Kolupaev, Luz A. Cuaboy, Amy L. Garrett, Karen McKinnon, Kristen Cowens, Dante Bortone, Benjamin C. Calhoun, Alec D. Wilkinson, Lisa Carey, Trevor Jolly, Hyman Muss, Katherine Reeder-Hayes, Rebecca Kaltman, Rachel Jankowitz, Vinay Gudena, Oludamilola Olajide, Charles Perou, E. Claire Dees, Benjamin G. Vincent, Jonathan S. Serody

Summary: This study evaluated the efficacy of using a low dose of cyclophosphamide (Cy) to deplete regulatory T cells (T-regs) before initiating pembrolizumab in patients with triple negative breast cancer (TNBC). The results showed that Cy did not significantly decrease T-regs before pembrolizumab and there was a rapid recovery in T-regs after the first cycle of therapy. Baseline samples with increased B cell gene expression were associated with clinical response and immune-related toxicity (IRT).

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients

Alina M. Hamilton, Amber N. Hurson, Linnea T. Olsson, Andrea Walens, Joseph Nsonwu-Farley, Erin L. Kirk, Yara Abdou, Stephanie M. Downs-Canner, Jonathan S. Serody, Charles M. Perou, Benjamin C. Calhoun, Melissa A. Troester, Katherine A. Hoadley

Summary: The immune microenvironment in breast cancer is closely related to race, age, tumor subtype, and grade. Black and young women have higher immune response, which may be associated with higher recurrence risk.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Oncology

Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics

Sonam Bhatia, Melissa Kramer, Suzanne Russo, Payal Naik, Gayatri Arun, Kyle Brophy, Peter Andrews, Cheng Fan, Charles M. Perou, Jonathan Preall, Taehoon Ha, Dennis Plenker, David A. Tuveson, Arvind Rishi, John E. Wilkinson, W. Richard McCombie, Karen Kostroff, David L. Spector

Summary: This study developed a diverse biobank of patient-derived organoids of triple-negative breast cancer (TNBC) and provided comprehensive insights into TNBC biology and progression. The organoids successfully recapitulated patient tumor characteristics and identified potential mechanisms of tumorigenesis at the single-cell level.

CANCER RESEARCH (2022)

Article Chemistry, Analytical

Early Notice Pointer, an IoT-like Platform for Point-of-Care Feet and Body Balance Screening

Florina Silvia Iliescu, Ling Tim Hong, Jin Ming Jaden Toh, Mirela Petruta Suchea, Octavian Narcis Ionescu, Ciprian Iliescu

Summary: Improper foot biomechanics and uneven bodyweight distribution can lead to balance impairments and increased risk of falls. This study presents the development of a user-friendly screening device, the Early Notice Pointer (ENP), based on weighing scale technology. The ENP is designed for at-home measurement of weight-shifting and provides foot and posture triage.

MICROMACHINES (2022)

Editorial Material Oncology

Challenges and Gaps in Clinical Trial Genomic Data Management

Sarah Asad, Kathryn Kananen, Kurt R. Mueller, W. Fraser Symmans, Yujia Wen, Charles M. Perou, James S. Blachly, James Chen, Benjamin G. Vincent, Daniel G. Stover

JCO CLINICAL CANCER INFORMATICS (2022)

Article Oncology

Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor-Positive Breast Cancer

Youli Xia, Xiaping He, Lorna Renshaw, Carlos Martinez-Perez, Charlene Kay, Mark Gray, James Meehan, Joel S. Parker, Charles M. Perou, Lisa A. Carey, J. Michael Dixon, Arran Turnbull

Summary: This study identified molecular mechanisms underlying endocrine therapy resistance (ETR) in hormone receptor-positive breast cancer through in-depth genomic analysis. The results showed that ETR involves diverse changes in somatic genetic and transcriptomic profiles, including mutations, gene expression changes, and activation of signaling pathways. Overcoming resistance will require an individualized approach utilizing genomic and genetic biomarkers and drugs tailored to each patient.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies

Audrey Y. Jung, Thomas U. Ahearn, Sabine Behrens, Pooja Middha, Manjeet K. Bolla, Qin Wang, Volker Arndt, Kristan J. Aronson, Annelie Augustinsson, Laura E. Beane Freeman, Heiko Becher, Hermann Brenner, Federico Canzian, Lisa A. Carey, Cts Consortium, Kamila Czene, A. Heather Eliassen, Mikael Eriksson, D. Gareth Evans, Jonine D. Figueroa, Lin Fritschi, Marike Gabrielson, Graham G. Giles, Pascal Guenel, Andreas Hadjisavvas, Christopher A. Haiman, Niclas Hakansson, Per Hall, Ute Hamann, Reiner Hoppe, John L. Hopper, Anthony Howell, David J. Hunter, Anika Huesing, Rudolf Kaaks, Veli-Matti Kosma, Stella Koutros, Peter Kraft, James Lacey, Loic Le Marchand, Jolanta Lissowska, Maria A. Loizidou, Arto Mannermaa, Tabea Maurer, Rachel A. Murphy, Andrew F. Olshan, Hakan Olsson, Alpa Patel, Charles M. Perou, Gad Rennert, Rana Shibli, Xiao-Ou Shu, Melissa C. Southey, Jennifer Stone, Rulla M. Tamimi, Lauren R. Teras, Melissa A. Troester, Therese Truong, Celine M. Vachon, Sophia S. Wang, Alicja Wolk, Anna H. Wu, Xiaohong R. Yang, Wei Zheng, Alison M. Dunning, Paul D. P. Pharoah, Douglas F. Easton, Roger L. Milne, Nilanjan Chatterjee, Marjanka K. Schmidt, Montserrat Garcia-Closas, Jenny Chang-Claude

Summary: Reproductive factors are differentially associated with risk of breast cancer subtypes, and triple-negative breast cancer has a distinct reproductive risk factor profile.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Oncology

Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study

Aatish Thennavan, Susana Garcia-Recio, Siyao Liu, Xiaping He, Charles M. Perou

Summary: Ductal carcinoma in situ (DCIS) of the breast is a precursor of invasive ductal carcinoma (IDC). This study utilizes mouse models and human samples to identify features associated with DCIS progression. The analysis reveals malignant cells and tumor microenvironmental changes in DCIS and IDC, and suggests the existence of intrinsic subtype unique DCIS features. The findings may contribute to the identification and treatment of progression-prone DCIS in human basal-like breast cancers.

NPJ BREAST CANCER (2022)

Review Chemistry, Analytical

Microfluidic trends in drug screening and drug delivery

Jianguo Feng, Jiri Neuzil, Andreas Manz, Ciprian Iliescu, Pavel Neuzil

Summary: The low success rate, time consumption, and high cost of bringing a drug from concept to market necessitate new approaches to drug discovery. Recent innovations in microfluidic technologies, such as organ-on-a-chip, droplet microfluidics, and high-throughput screening, have shown potential in addressing these challenges through reduced sample volume, faster processing time, and improved process control. This review highlights the recent progress in the development and application of microfluidic technologies in drug screening and drug delivery, outlining the trends and associated challenges.

TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2023)

Article Oncology

Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs

David C. Boyd, Emily K. Zboril, Amy L. Olex, Tess J. Leftwich, Nicole S. Hairr, Holly A. Byers, Aaron D. Valentine, Julia E. Altman, Mohammad A. Alzubi, Jacqueline M. Grible, Scott A. Turner, Andrea Ferreira-Gonzalez, Mikhail G. Dozmorov, J. Chuck Harrell

Summary: Basal-like breast cancers, which are the majority of triple-negative breast cancers, have high levels of PI3K pathway activity and are difficult to treat. PI3K inhibitors as single agents have limited efficacy in TNBC patients. This study aimed to identify drug combinations that can effectively inhibit tumor growth when used in conjunction with PI3K inhibitors.

CANCERS (2023)

Article Oncology

Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence

Frederick M. Howard, James Dolezal, Sara Kochanny, Galina Khramtsova, Jasmine Vickery, Andrew Srisuwananukorn, Anna Woodard, Nan Chen, Rita Nanda, Charles M. Perou, Olufunmilayo I. Olopade, Dezheng Huo, Alexander T. Pearson

Summary: Gene expression-based recurrence assays are recommended for guiding chemotherapy in hormone receptor-positive, HER2-negative breast cancer, but their high cost and limited availability pose challenges. This study presents a deep learning model that utilizes digital histology and clinical risk factors to predict recurrence assay results and the risk of recurrence, surpassing the performance of established clinical nomograms. The model can identify patients with excellent prognoses who may not require further genomic testing.

NPJ BREAST CANCER (2023)

Review Biochemistry & Molecular Biology

Trends in Photothermal Nanostructures for Antimicrobial Applications

Violeta Dediu, Jana Ghitman, Gratiela Gradisteanu Pircalabioru, Kiat Hwa Chan, Florina Silvia Iliescu, Ciprian Iliescu

Summary: The rapid development of antimicrobial resistance due to broad antibiotic utilization in healthcare and food industries is a critical global public health issue. Nanotechnology offers new materials with unique properties and adaptability to address drug-resistant bacterial infections in safe and targeted ways. Photothermal antibacterial nanomaterials, such as plasmonic metals, semiconductors, and organic polymers, show promise in developing controllable hyperthermia as antibacterial platforms. This review discusses the current state of the art in photothermal antibacterial nanomaterials, strategies for optimizing antimicrobial efficiency, antibacterial mechanisms, and potential applications in biofilm removal and infected wound therapy. The challenges, limitations, and future perspectives of photothermal antimicrobial therapy are also explored.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

暂无数据